Through in vivo and ex vivo experiments, we demonstrated that CTCF promotes the transcription of Migration and Invasion Enhancer 1 (MIEN1), enhancing neutrophil migration toward cancer cells, and stimulates IL-1β secretion, leading to a malignant phenotype in CRC cells. The gene discussed is IL1B; the disease is colorectal carcinoma.